Symptomatic patients with heart failure (men and women) aged >18 years,
Functional class II, III or IV by the New York Heart Association (NYHA)
Left ventricular ejection fraction <35%
Ischemic and nonischemic etiology
Type B natriuretic peptide (BNP) >150 pg/ml (or pro-BNP [N-terminal-proBNP] = 600 pg / ml) or if the patient was hospitalized for cardiac decompensation within the preceding 12 months, BNP >100 pg/ml (or N-terminal-proBNP = 400 pg / ml)

NCT03190304_inc_T1
Condition
heart failure
NCT03190304_inc_T2
Person
men
NCT03190304_inc_T3
Person
women
NCT03190304_inc_T4
Person
aged
NCT03190304_inc_T5
Value
>18 years
NCT03190304_inc_T7
Condition
Symptomatic
NCT03190304_inc_T6
Measurement
New York Heart Association (NYHA)
NCT03190304_inc_T8
Value
Functional class II, III or IV
NCT03190304_inc_T9
Measurement
Left ventricular ejection fraction
NCT03190304_inc_T10
Value
<35%
NCT03190304_inc_T11
Condition
hemic an ology
Ty
NCT03190304_inc_T12
Condition
nonischemic etiology
NCT03190304_inc_T13
Measurement
Type B natriuretic peptide (BNP)
NCT03190304_inc_T14
Value
>150 pg/ml
NCT03190304_inc_T15
Measurement
pro-BNP [N-terminal-proBNP]
NCT03190304_inc_T16
Value
= 600 pg / ml
NCT03190304_inc_T17
Procedure
hospitalized
NCT03190304_inc_T18
Condition
cardiac decompensation
NCT03190304_inc_T19
Temporal
within the preceding 12 months
NCT03190304_inc_T20
Scope
hospitalized for cardiac decompensation within the preceding 12 months
NCT03190304_inc_T21
Measurement
BNP
NCT03190304_inc_T22
Value
>100 pg/ml
NCT03190304_inc_T23
Measurement
N-terminal-proBNP
NCT03190304_inc_T24
Value
= 400 pg / ml
NCT03190304_inc_T25
Scope
BNP >100 pg/ml (or N-terminal-proBNP = 400 pg / ml)
NCT03190304_inc_T26
Scope
Type B natriuretic peptide (BNP) >150 pg/ml (or pro-BNP [N-terminal-proBNP] = 600 pg / ml)